Effect of Dural Substitute and Technique on Cranioplasty Operative Metrics: A Systematic Literature Review

Raghavan, Alankrita; Wright, James; Wright, Christina Huang; Sajatovic, Martha; Miller, Jonathan P.

doi:10.1016/j.wneu.2018.08.024

Cited by 20 publications

(4 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The postoperative infection rate following duraplasty with collagen matrix ranges from 2%–17%, with some variation according to the indication and site of placement [ 4 8 10 15 22 23 24 25 26 27 28 29 30 31 32 ]. The postoperative infection rate of 6% in our series falls within an acceptable range and is comparable to rates of similar studies [ 4 10 26 31 ].…”

Section: Discussionmentioning

confidence: 99%

A Case Series of DuraMatrix-Onlay^® Plus in Cranial Surgery Is Associated With a Low Complication Profile

Mekonnen,

Hovis,

Mahgerefteh

et al. 2023

Brain Tumor Res Treat

View full text Add to dashboard Cite

Background DuraMatrix-Onlay ® Plus is a collagen dura membrane derived from purified bovine Achilles tendon. The matrix provides a scaffold for collagen synthesis and is intended to be used as an onlay without the need for dural sutures. The study aims to describe our experience with 33 consecutive patients who underwent a duraplasty procedure using the novel DuraMatrix-Onlay ® Plus collagen dura membrane. Methods This is a retrospective case series of 33 patients who underwent a duraplasty procedure at a single academic hospital in Los Angeles, CA, USA between May 2016 and March 2017. The primary outcome was the incidence rate of cerebrospinal fluid (CSF) leak. Secondary outcomes included rates of patient infection, dural substitute complication, and removal. Results Thirty-three patients underwent a duraplasty procedure using the DuraMatrix-Onlay ® Plus material. The average age of the patients was 41.12±7.34 years (range 2–75 years). There were 18 (54.5%) females and 15 (45.5%) males. The majority of procedures were elective operations for the resection of a lesion (n=19, 58%), and the average graft size was 17.69±4.73 cm 2 . At an average follow-up of 3 months, there were no postoperative CSF leaks. The rates of patient infection, dural substitute complication, and removal were 6%, 6%, and 3%, respectively. Conclusion DuraMatrix-Onlay ® Plus is associated with a low rate of postoperative CSF leakage and an acceptable complication profile. This result supports the use of collagen matrices for dural closure in general neurosurgical procedures.

show abstract

Section: Discussionmentioning

confidence: 99%

A Case Series of DuraMatrix-Onlay^® Plus in Cranial Surgery Is Associated With a Low Complication Profile

Mekonnen,

Hovis,

Mahgerefteh

et al. 2023

Brain Tumor Res Treat

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…[14,20] As a result, various synthetic and biological substitutes are commonly used in dural repair. [19] HAM grafting has been used in various surgical fields since 1910, although its use in neurosurgery as a dural substitute was not reported till more than a century later. [15] In 2012, Tomita et al reported the first ever use of HAM as a dural substitute in humans after which subsequent studies evaluating HAM as a dural substitute have also reported favorable characteristics of HAM for dural repair.…”

Section: Mean Age In Years (Range) Indication For Surgery (N)mentioning

confidence: 99%

Human amniotic membrane as a dural substitute in neurosurgery: A systematic review

Shah

Bakhshi

Bajwa

et al. 2022

Surgical Neurology International

View full text Add to dashboard Cite

Background: Several studies have highlighted the use of human amniotic membrane (HAM) in neurosurgical procedures as an effective dural substitute. HAM has inherent antifibrotic and anti-inflammatory properties and exhibits immunomodulatory effect that makes it an ideal dural substitute. Other advantages including easy availability, low cost of procurement, and storage also render it a promising dural substitute especially in low- and middle-income countries. Methods: A systematic literature search was performed using PubMed, Scopus, and Google Scholar databases, using the search terms “human amniotic membrane,” “dural repair,” and “neurosurgery.” To be eligible for inclusion in our review, papers had to report primary data, be published in English language and report dural repair on humans with human amniotic membrane. Eligibility assessment was conducted by two independent reviewers with qualitative analysis on the basis of surgical utility, postoperative complications, and histological analysis. Results: Eight articles met the predefined inclusion criteria, including three randomized control trials and five cohort studies. We evaluated the use of HAM grafts in dural repair for elective cranial surgery (four studies), trauma surgery (three studies), and elective spine surgery (one study). Cases with postoperative cerebrospinal fluid (CSF) leak were reported by two studies. Other postoperative complications including meningitis, hydrocephalus, pseudomeningocele, CSF collection in subdural space, and subacute subdural hematoma were reported by one study each. Postsurgical histological analysis was reported by three studies highlighting the antiadhesive and integrative properties of HAM. Conclusion: The current review of evidence suggests that in terms of postsurgical outcomes, HAM is comparable with commercially available dural substitutes.

show abstract

“…When additional strength of the native dural layer and tissue gliding are required, duraplasty may benefit from dural substitutes (synthetic or autologous) to lower the incidence of adhesions between the neurological layers and therefore prevent postoperative tethering of the spinal cord [3].…”

Section: Introductionmentioning

confidence: 99%

Myelomeningocele Repair Combining a Double Cryopreserved Amniotic Membrane Homograft and the Keystone Flap in a 3-Year-Old Child: A Case Report

et al. 2020

View full text Add to dashboard Cite

• Severe forms of myelomeningocele are usually fatal if not treated early. • Treatment needs neurosurgical repair and adequate, long-lasting soft tissue coverage. • Only a few cases of the use of cryopreserved amniotic membrane (AM) homograft as an adjunct to dural repair have been reported. Novel Insights • The unusual advanced age of the patient, a 3-year-old child, with severe myelomeningocele. • The use, for the first time, of combining treatment involving a double cryopreserved AM homograft and a bilateral Keystone flap to reconstruct the dural layer and the soft tissue defect caused by the large myelomeningocele.

show abstract

Effect of Dural Substitute and Technique on Cranioplasty Operative Metrics: A Systematic Literature Review

Cited by 20 publications

References 18 publications

A Case Series of DuraMatrix-Onlay^® Plus in Cranial Surgery Is Associated With a Low Complication Profile

A Case Series of DuraMatrix-Onlay^® Plus in Cranial Surgery Is Associated With a Low Complication Profile

Human amniotic membrane as a dural substitute in neurosurgery: A systematic review

Myelomeningocele Repair Combining a Double Cryopreserved Amniotic Membrane Homograft and the Keystone Flap in a 3-Year-Old Child: A Case Report

Contact Info

Product

Resources

About

Effect of Dural Substitute and Technique on Cranioplasty Operative Metrics: A Systematic Literature Review

Cited by 20 publications

References 18 publications

A Case Series of DuraMatrix-Onlay® Plus in Cranial Surgery Is Associated With a Low Complication Profile

A Case Series of DuraMatrix-Onlay® Plus in Cranial Surgery Is Associated With a Low Complication Profile

Human amniotic membrane as a dural substitute in neurosurgery: A systematic review

Myelomeningocele Repair Combining a Double Cryopreserved Amniotic Membrane Homograft and the Keystone Flap in a 3-Year-Old Child: A Case Report

Contact Info

Product

Resources

About

A Case Series of DuraMatrix-Onlay^® Plus in Cranial Surgery Is Associated With a Low Complication Profile

A Case Series of DuraMatrix-Onlay^® Plus in Cranial Surgery Is Associated With a Low Complication Profile